Ramin Rahmanzade

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Journal: Acta neuropathologica

Published: February 21, 2026

Sciatic Schwannoma in a Patient with Neurofibromatosis Type 1: A Report of a Minimally Invasive Surgical Technique and Review of the Literature.

Sciatic Schwannoma in a Patient with Neurofibromatosis Type 1: A Report of a Minimally Invasive Surgical Technique and Review of the Literature.

Journal: Cureus

Published: January 07, 2026

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Journal: Nature cancer

Published: July 26, 2025

Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients?

Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients?

Journal: Neuro-oncology

Published: July 22, 2025

Advancing sarcoma diagnostics with expanded DNA methylation-based classification.

Advancing sarcoma diagnostics with expanded DNA methylation-based classification.

Journal: medRxiv : the preprint server for health sciences

Published: July 09, 2025

High-grade, metastatic disease, and adjuvant radiotherapy are independent prognostic factors for progression-free survival in patients with solitary fibrous tumors.

High-grade, metastatic disease, and adjuvant radiotherapy are independent prognostic factors for progression-free survival in patients with solitary fibrous tumors.

Journal: Neuro-oncology advances

Published: June 04, 2025

Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10.

Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10.

Journal: Acta neuropathologica

Published: January 26, 2025

A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification.

A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification.

Journal: Nature genetics

Published: October 30, 2024

Reply: pineal parenchymal tumors of intermediate differentiation: in need of a stringent definition to avoid confusion.

Reply: pineal parenchymal tumors of intermediate differentiation: in need of a stringent definition to avoid confusion.

Journal: Acta neuropathologica

Published: January 03, 2024

Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.

Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.

Journal: Acta neuropathologica

Published: August 17, 2023

Accessory nerve schwannoma extending into the fourth ventricle: case report and review of literature.

Accessory nerve schwannoma extending into the fourth ventricle: case report and review of literature.

Journal: British journal of neurosurgery

Published: February 17, 2023

Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.

Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.

Journal: Acta neuropathologica

Published: January 04, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026